Pfizer shifts work on Wyeth's Advil to McGarryBowen

Share this article:
Pfizer Consumer Healthcare awarded McGarryBowen another big Pfizer account, handing the shop the bulk of its heavily advertised Advil business following a competitive pitch.

The incumbent on the account was WPP's ghg. The move was first reported by Advertising Age, which said the indie victor also pitched against WPP's Ogilvy and Havas' Arnold for the business.

McGarryBowen will handle advertising for Advil, Advil PM, Children's Advil and Advil ThermaCare. McGarryBowen is also agency of record for Pfizer's Viagra and Chantix. As a consolation prize, ghg will hold onto Advil Cold and Sinus, as well as Pfizer's Robitussin, Dimetapp and Alavert, according to Ad Age.

A Pfizer spokesperson said other shops handle digital, PR and experiential marketing for the brand, but declined to say which ones.

A 2009 TV and print campaign tried to sell the ibuprofen brand as “The Every Pain Reliever,” an all-in-one analgesic that could unclutter their purses with just one bottle for bachache, headache and joint pains. Pitched at young moms, those ads ran with the tagline “Yes, Advil.”

Pfizer acquired Advil as part of its acquisition of Wyeth last year. The company previously named Omnicom's Tribal DDB to handle digital for Advil and consolidated all media buying for Wyeth DTC under Carat.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?